2010Inner Mongolia Medical JournalRequires access

Expression of CD44v6 and the Relationship of Prognosis in Human Gastric Carcinoma

Hua Yun-qi

Open publisher page 0 citations

Abstract

Objective:The aim of this study is to observe the expression of CD44v6 in gastric carcinoma and analysis the relationship of prognosis between CD44v6 expression and metastases in gastric carcinoma preliminarily.Methods:From 2006 to 2008,49 patients with gastric carcinoma were studied.The expression of CD44v6 in gastric carcinoma was determined by immunohistochemistry.Results: 49 cases of gastric carcinoma in patients position rate of CD44v6 was 55.10%(27/49).Using standard chemotherapy regimen for CD44v6+ and CD44v6-groups,the rate of clinical efficient was 31.82%(7/22) and 22.22%(6/27) respectively.There was significant difference between two groups(P0.05).Conclusions: Cell adhesion molecule CD44v6 is highly expressed in gastric carcinoma.CD44v6 expression is correlated with a poor prognosis in gastric carcinoma.CD44v6 can,therefore,be utilized as a prognostic marker for this group of patients.

About this research paper

What this paper is about

Objective:The aim of this study is to observe the expression of CD44v6 in gastric carcinoma and analysis the relationship of prognosis between CD44v6 expression and metastases in gastric carcinoma preliminarily.Methods:From 2006 to 2008,49 patients with gastric carcinoma were studied.The expression of CD44v6 in gastric carcinoma was determined by immunohistochemistry.Results: 49 cases of gastric carcinoma in patients position rate of CD44v6 was 55.10%(27/49).Using standard chemotherapy regimen for CD44v6+ and CD44v6-groups,the rate of clinical efficient was 31.82%(7/22) and 22.22%(6/27) respectively.There was significant difference between two groups(P0.05).Conclusions: Cell adhesion molecule CD44v6 is highly expressed in gastric carcinoma.CD44v6 expression is correlated with a poor prognosis in gastric carcinoma.CD44v6 can,therefore,be utilized as a prognostic marker for this group of patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:The aim of this study is to observe the expression of CD44v6 in gastric carcinoma and analysis the relationship of prognosis between CD44v6 expression and metastases in gastric carcinoma preliminarily.Methods:From 2006 to 2008,49 patients with gastric carcinoma were studied.The expression of CD44v6 in gastric carcinoma was determined by immunohistochemistry.Results: 49 cases of gastric carcinoma in patients position rate of CD44v6 was 55.10%(27/49).Using standard chemotherapy regimen for CD44v6+ and CD44v6-groups,the rate of clinical efficient was 31.82%(7/22) and 22.22%(6/27) respectively.There was significant difference between two groups(P0.05).Conclusions: Cell adhesion molecule CD44v6 is highly expressed in gastric carcinoma.CD44v6 expression is correlated with a poor prognosis in gastric carcinoma.CD44v6 can,therefore,be utilized as a prognostic marker for this group of patients.

Key concepts: Medicine, Gastric carcinoma, Immunohistochemistry, Internal medicine, Gastroenterology, Carcinoma, Significant difference, Oncology

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of CD44v6 and the Relationship of Prognosis in Human Gastric Carcinoma — Research Paper | ScholarLens